PharmaCyte Biotech's total assets for Q were $70.19M, an increase of 17.18% from the previous quarter. PMCB total liabilities were $17.15M for the fiscal quarter, a -15.87% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.